Equillium, Inc. (EQ)
NASDAQ: EQ · Real-Time Price · USD
1.530
-0.020 (-1.29%)
At close: Jan 2, 2026, 4:00 PM EST
1.500
-0.030 (-1.96%)
After-hours: Jan 2, 2026, 7:51 PM EST
Equillium Market Cap
Equillium has a market cap or net worth of $93.17 million as of January 2, 2026. Its market cap has increased by 310.87% in one year.
Market Cap
93.17M
Enterprise Value
60.79M
1-Year Change
310.87%
Ranking
Category
Stock Price
$1.53
Market Cap Chart
Since October 12, 2018, Equillium's market cap has decreased from $234.54M to $93.17M, a decrease of -60.28%. That is a compound annual growth rate of -11.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 2, 2026 | 93.17M | -1.29% |
| Dec 31, 2025 | 94.38M | 256.04% |
| Dec 31, 2024 | 26.51M | 4.40% |
| Dec 29, 2023 | 25.39M | -30.27% |
| Dec 30, 2022 | 36.41M | -67.14% |
| Dec 31, 2021 | 110.80M | -16.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 12, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 962.25B |
| Johnson & Johnson | 498.60B |
| AbbVie | 403.83B |
| UnitedHealth Group | 299.03B |
| AstraZeneca | 287.81B |
| Novartis AG | 266.00B |
| Merck & Co. | 261.26B |
| Novo Nordisk | 227.63B |